KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Inventory (2018 - 2025)

ClearPoint Neuro's Inventory history spans 13 years, with the latest figure at $6.6 million for Q3 2025.

  • For Q3 2025, Inventory fell 6.74% year-over-year to $6.6 million; the TTM value through Sep 2025 reached $6.6 million, down 6.74%, while the annual FY2024 figure was $6.9 million, 13.25% down from the prior year.
  • Inventory for Q3 2025 was $6.6 million at ClearPoint Neuro, up from $6.3 million in the prior quarter.
  • Across five years, Inventory topped out at $9.8 million in Q1 2023 and bottomed at $3.3 million in Q1 2021.
  • The 5-year median for Inventory is $6.9 million (2024), against an average of $6.9 million.
  • The largest annual shift saw Inventory skyrocketed 110.09% in 2022 before it decreased 21.64% in 2025.
  • A 5-year view of Inventory shows it stood at $4.9 million in 2021, then soared by 88.4% to $9.3 million in 2022, then dropped by 14.96% to $7.9 million in 2023, then dropped by 13.25% to $6.9 million in 2024, then fell by 4.08% to $6.6 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Inventory are $6.6 million (Q3 2025), $6.3 million (Q2 2025), and $6.6 million (Q1 2025).